Summary
The pharmacokinetics of terodiline HCl was studied in nine healthy volunteers given 12.5 mg i.v. and p.o. or 20 mg i.v. and 25 mg p.o. on two different occasions. The serum concentrations were measured by gas chromatography — mass spectrometry, using deuterated terodiline HCl as the internal standard. After i.v. administration the kinetics could be described by a two-compartment model with a mean distribution half life of 0.3 h and a mean elimination half life of 63 h. The serum clearance and apparent volume of distribution varied about 4-fold with mean values of 4.8 l/h and 417 l, respectively. After oral administration, the mean half life of absorption was 0.7 h and that of elimination 65 h. The absolute bioavailability varied between 64% and 105% with a mean of 92%. The long serum half life of terodiline should permit its once daily administration.
Similar content being viewed by others
References
Andersson K-E, Ulmsten U (1980) Drug treatment of the overactive detrusor. Acta Pharmacol Toxicol 46 (Suppl I): 7–11
v. Bahr C, Hedlund I, Karlén B, Bäckström D, Grasdalen H (1977) Evidence for two catalytically different binding sites of liver microsomal cytochrome P-450. Importance for species and sex differences in oxidation pattern of lidocaine. Acta Pharmacol Toxicol 41: 39–48
Husted S, Andersson K-E, Sommer L, Østergaard JR (1980) Anticholinergic and calcium antagonistic effect of terodiline in rabbit urinary bladder. Acta Pharmacol Toxicol 46 (Suppl I): 20–30
Ekman G, Andersson K-E, Rud T, Ulmsten U (1980) A double-blind cross-over study of the effects of terodiline in women with unstable bladder. Acta Pharmacol Toxicol 46 (Suppl I): 39–43
Lindeke B, Cho AK (1982) In: Jacobi VB, Bend JR, Caldwell J (eds) Metabolic basis of detoxication. Academic Press, New York, pp 105–126
Rud T, Andersson K-E, Boye N, Ulmsten U (1980) Terodiline inhibition of human bladder contraction. Effects in vitro and in women with unstable bladder. Acta Pharmacol Toxicol 46 (Suppl I): 31–38
Vessman J, Strömberg S (1969) Determination of terodiline (Bicor®) in serum by gas chromatography and electron capture detection of benzophenone formed by chromic acid oxidation. Acta Pharm Suec 6: 508–518
Vessman J, Sundwall A (1970) Identification of hydroxylated metabolites of terodiline in animal and man. Acta Pharmacol Toxicol 28 (Suppl I): 89
Østergaard JR, Østergaard K, Andersson K-E, Sommer L (1980) Calcium antagonistic effect of terodiline in rabbit aorta and human uterus. Acta Pharmacol Toxicol 46 (Suppl I): 12–19
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karlén, B., Andersson, K.E., Ekman, G. et al. Pharmacokinetics of terodiline in human volunteers. Eur J Clin Pharmacol 23, 267–270 (1982). https://doi.org/10.1007/BF00547566
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00547566